{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:01:58Z","timestamp":1786978918646,"version":"build-2736575974"},"reference-count":55,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","issue":"spe3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"DOI":"10.31744\/einstein_journal\/2026rw2547","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:26Z","timestamp":1786976066000},"source":"Crossref","is-referenced-by-count":0,"title":["Current challenges and emerging solutions in dentistry for treating medication-related osteonecrosis of the jaw (MRONJ): the state of the art in the era of personalized medicine"],"prefix":"10.31744","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4190-7931","authenticated-orcid":false,"given":"St\u00e9fany Barbosa Alves da","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-3807","authenticated-orcid":false,"given":"Mirela Caroline da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-5539","authenticated-orcid":false,"given":"Mileni","family":"Buzo-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2183-7367","authenticated-orcid":false,"given":"Gabriela Fulanetto","family":"Crestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-7238","authenticated-orcid":false,"given":"Fernanda","family":"Faot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-0508","authenticated-orcid":false,"given":"Leticia Mello","family":"Bezinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1971-0195","authenticated-orcid":false,"given":"Jamil Awad","family":"Shibli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-3048","authenticated-orcid":false,"given":"Leonardo Perez","family":"Faverani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"11","key":"key20260817141420_B1","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","unstructured":"1 Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, et al. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg. 2010;68(11):2837-45.","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"key20260817141420_B2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","unstructured":"2 Chang J, Hakam AE, McCauley LK. Current understanding of the pathophysiology of osteonecrosis of the jaw. Curr Osteoporos Rep. 2018; 16(5):584-95.","journal-title":"Curr Osteoporos Rep"},{"issue":"19","key":"key20260817141420_B3","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.3390\/ijms20194925","article-title":"From osteoclast differentiation to osteonecrosis of the jaw: molecular and clinical insights","volume":"20","author":"Anesi","year":"2019","unstructured":"3 Anesi A, Generali L, Sandoni L, Pozzi S, Grande A. From osteoclast differentiation to osteonecrosis of the jaw: molecular and clinical insights. Int J Mol Sci. 2019;20(19):4835.","journal-title":"Int J Mol Sci"},{"key":"key20260817141420_B4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","unstructured":"4 Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155-70.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"53","key":"key20260817141420_B5","doi-asserted-by":"crossref","first-page":"lgz009","DOI":"10.1093\/jncimonographs\/lgz009","article-title":"Medication-related osteonecrosis of the jaws","volume":"2019","author":"Migliorati","year":"2019","unstructured":"5 Migliorati CA, Brennan MT, Peterson DE. Medication-related osteonecrosis of the jaws. JNCI Monogr. 2019;2019(53):lgz009.","journal-title":"JNCI Monogr"},{"issue":"6","key":"key20260817141420_B6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-023-06745-3","article-title":"Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?","volume":"34","author":"Hasegawa","year":"2023","unstructured":"6 Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T; Japanese Study Group of Cooperative Dentistry with Medicine (JCDM). Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int. 2023;34(6):1141-1144. Erratum for: Osteoporos Int. 2017;28(8):2465-73.","journal-title":"Osteoporos Int"},{"issue":"5","key":"key20260817141420_B7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","unstructured":"7 Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update. J Oral Maxillofac Surg. 2022;80(5):920-43.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"key20260817141420_B8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors","volume":"8","author":"Wan","year":"2020","unstructured":"8 Wan JT, Sheeley DM, Somerman MJ, Lee JS. Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res. 2020;8(1):14.","journal-title":"Bone Res"},{"issue":"4","key":"key20260817141420_B9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/dj4040036","article-title":"Impact of soft tissue pathophysiology in the development and maintenance of bisphosphonate-related osteonecrosis of the jaw","volume":"4","author":"Ziebart","year":"2016","unstructured":"9 Ziebart T, Halling F, Heymann P, Neff A, Blatt S, Jung J, et al. Impact of soft tissue pathophysiology in the development and maintenance of bisphosphonate-related osteonecrosis of the jaw. Dent J. 2016;4(4):36.","journal-title":"Dent J"},{"issue":"5","key":"key20260817141420_B10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00784-018-2655-z","article-title":"Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw","volume":"23","author":"Zirk","year":"2019","unstructured":"10 Zirk M, Wenzel C, Buller J, Z\u00f6ller JE, Zinser M, Peters F. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw. Clin Oral Investig. 2019;23(5):2143-51.","journal-title":"Clin Oral Investig"},{"issue":"11","key":"key20260817141420_B11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10096-014-2160-5","article-title":"Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?","volume":"33","author":"De Ceulaer","year":"2014","unstructured":"11 De Ceulaer J, Tacconelli E, Vandecasteele SJ. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? Eur J Clin Microbiol Infect Dis. 2014;33(11):1873-80.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"key20260817141420_B12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jop.12963","article-title":"Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"49","author":"Lorenzo-Pouso","year":"2020","unstructured":"12 Lorenzo-Pouso AI, P\u00e9rez-Say\u00e1ns M, Chamorro-Petronacci C, G\u00e1ndara-Vila P, L\u00f3pez-Jornet P, Carballo J, et al. Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. J Oral Pathol Med. 2020;49(3):190-200.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"key20260817141420_B13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/JPER.21-0611","article-title":"Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: a national cohort-based study","volume":"94","author":"Kwoen","year":"2023","unstructured":"13 Kwoen MJ, Park JH, Kim KS, Lee JR, Kim JW, Lee H, et al. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: a national cohort-based study. J Periodontol. 2023;94(1):98-107.","journal-title":"J Periodontol"},{"issue":"7","key":"key20260817141420_B14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/odi.13412","article-title":"Endothelial progenitors increase vascularization and improve fibroblasts function that prevent medication-related osteonecrosis of the jaw","volume":"26","author":"Doppelt","year":"2020","unstructured":"14 Doppelt O, Cohen G, Tamari T, Elimelech R, Sabbah N, Zigdon-Giladi H. Endothelial progenitors increase vascularization and improve fibroblasts function that prevent medication-related osteonecrosis of the jaw. Oral Dis. 2020;26(7):1523-31.","journal-title":"Oral Dis"},{"issue":"6","key":"key20260817141420_B15","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/odi.14887","article-title":"Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ)","volume":"30","author":"Bedogni","year":"2024","unstructured":"15 Bedogni A, Mauceri R, Fusco V, Bertoldo F, Bettini G, Di Fede O, et al. Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). Oral Dis. 2024;30(6):3679-709.","journal-title":"Oral Dis"},{"issue":"9","key":"key20260817141420_B16","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00784-018-2385-2","article-title":"Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat","volume":"22","author":"K\u00fcn-Darbois","year":"2018","unstructured":"16 K\u00fcn-Darbois JD, Libouban H, Mabilleau G, Pascaretti-Grizon F, Chappard D. Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat. Clin Oral Investig. 2018;22(9):2997-3006.","journal-title":"Clin Oral Investig"},{"issue":"1","key":"key20260817141420_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-5-1","article-title":"Bisphosphonate-related osteonecrosis of jaw: diagnostic criteria and possible pathogenic mechanisms","volume":"5","author":"Sharma","year":"2013","unstructured":"17 Sharma D, Ivanovski S, Slevin M, Hamlet S, Pop TS, Brinzaniuc K, et al. Bisphosphonate-related osteonecrosis of jaw: diagnostic criteria and possible pathogenic mechanisms. Vasc Cell. 2013;5(1):1.","journal-title":"Vasc Cell"},{"issue":"4","key":"key20260817141420_B18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/ger.12416","article-title":"Medication-related osteonecrosis of the jaw-like lesions in rodents: a comprehensive systematic review and meta-analysis","volume":"36","author":"Kuroshima","year":"2019","unstructured":"18 Kuroshima S, Sasaki M, Murata H, Sawase T. Medication-related osteonecrosis of the jaw-like lesions in rodents: a comprehensive systematic review and meta-analysis. Gerodontology. 2019;36(4):313-24.","journal-title":"Gerodontology"},{"issue":"8","key":"key20260817141420_B19","first-page":"1947","article-title":"Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: a systematic review","volume":"27","author":"Martins","year":"2021","unstructured":"19 Martins LH, Ferreira DC, Silva MT, Motta RH, Franquez RT, Bergamaschi CC. Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: a systematic review. Oral Dis. 2021;27(8):1947-59.","journal-title":"Oral Dis"},{"issue":"2","key":"key20260817141420_B20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oooo.2021.03.006","article-title":"Quality of life in patients affected by medication-related osteonecrosis of the jaws: a systematic review","volume":"132","author":"Bensi","year":"2021","unstructured":"20 Bensi C, Giovacchini F, Lomurno G, Eramo S, Barraco G, Tullio A. Quality of life in patients affected by medication-related osteonecrosis of the jaws: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;132(2):182-9.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"key20260817141420_B21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","unstructured":"21 Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Dabagh RA, Davison KS, S\u00e1ndor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for management from the international task force on ONJ. J Clin Densitom. 2017;20(1):8-24. Review.","journal-title":"J Clin Densitom"},{"key":"key20260817141420_B22","doi-asserted-by":"crossref","first-page":"606043","DOI":"10.3389\/fimmu.2021.606043","article-title":"The role of the immune response in the development of medication-related osteonecrosis of the jaw","volume":"12","author":"Zhang","year":"2021","unstructured":"22 Zhang W, Gao L, Ren W, Li S, Zheng J, Li S, et al. The role of the immune response in the development of medication-related osteonecrosis of the jaw. Front Immunol. 2021;12:606043.","journal-title":"Front Immunol"},{"issue":"3","key":"key20260817141420_B23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","unstructured":"23 Raje N, Terpos E, Willenbacher W, Shimizu K, Garc\u00eda-Sanz R, Durie B, et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018;19(3):370-81.","journal-title":"Lancet Oncol"},{"issue":"9","key":"key20260817141420_B24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","article-title":"Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE trial","volume":"15","author":"Coleman","year":"2014","unstructured":"24 Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E, et al. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE trial. Lancet Oncol. 2014;15(9):997-1006.","journal-title":"Lancet Oncol"},{"issue":"1","key":"key20260817141420_B25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2016.19425","article-title":"Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial","volume":"317","author":"Himelstein","year":"2017","unstructured":"25 Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, et al. Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial. JAMA. 2017;317(1):48-58.","journal-title":"JAMA"},{"issue":"9992","key":"key20260817141420_B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","unstructured":"26 Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(9992):433-43.","journal-title":"Lancet"},{"issue":"2","key":"key20260817141420_B27","first-page":"925","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","unstructured":"27 Ng TL, Tu MM, Ibrahim MF, Basulaiman B, McGee SF, Srikanthan A, et al. Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Support Care Cancer. 2021;29(2):925-43.","journal-title":"Support Care Cancer"},{"issue":"15","key":"key20260817141420_B28","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","unstructured":"28 Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417-27.","journal-title":"N Engl J Med"},{"issue":"6","key":"key20260817141420_B29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","unstructured":"29 Hallmer F, Andersson G, G\u00f6trick B, Warfvinge G, Anderud J, Bj\u00f8rnland T. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126(6):477-85.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"key20260817141420_B30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","unstructured":"30 Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. 2017;5(7):513-23.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"key20260817141420_B31","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","unstructured":"31 Henry D, Vadhan-Raj S, Hirsh V, von Moos R, Hungria V, Costa L, et al. Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Support Care Cancer. 2014;22(3):679-87.","journal-title":"Support Care Cancer"},{"issue":"25","key":"key20260817141420_B32","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","unstructured":"32 Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, et al. Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol. 2019;37(25):2270-90.","journal-title":"J Clin Oncol"},{"issue":"5","key":"key20260817141420_B33","first-page":"2519","article-title":"Italian consensus update on medication-related osteonecrosis of the jaws (MRONJ) by SIPMO-SICMF","volume":"30","author":"Bedogni","year":"2024","unstructured":"33 Bedogni A, Campisi G, Fusco V, Mauceri R, Agrillo A, Bettini G, et al. Italian consensus update on medication-related osteonecrosis of the jaws (MRONJ) by SIPMO-SICMF. Oral Dis. 2024;30(5):2519-40.","journal-title":"Oral Dis"},{"issue":"4","key":"key20260817141420_B34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","unstructured":"34 McGowan K, McGowan T, Ivanovski S. Risk factors for medication-related osteonecrosis of the jaws: A systematic review. Oral Dis. 2018;24(4):527-36.","journal-title":"Oral Dis"},{"issue":"8","key":"key20260817141420_B35","first-page":"2456","article-title":"Medication-related osteonecrosis of jaws: prevention, diagnosis and treatment","volume":"9","author":"Campisi","year":"2020","unstructured":"35 Campisi G, Mauceri R, Bertoldo F, Fusco V, Bedogni A, Colella G, et al. Medication-related osteonecrosis of jaws: prevention, diagnosis and treatment. J Clin Med. 2020;9(8):2456.","journal-title":"J Clin Med"},{"issue":"4","key":"key20260817141420_B36","first-page":"1233","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases","volume":"52","author":"Alm\u0103\u015fan","year":"2011","unstructured":"36 Alm\u0103\u015fan HA, B\u0103ciu\u0163 M, Rotaru H, Bran S, Alm\u0103\u015fan OC, B\u0103ciu\u0163 G. Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases. Rom J Morphol Embryol. 2011;52(4):1233-41.","journal-title":"Rom J Morphol Embryol"},{"issue":"4","key":"key20260817141420_B37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","unstructured":"37 Aghaloo T, Hazboun R, Tetradis S. Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am. 2015;27(4):489-96.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"5 Suppl","key":"key20260817141420_B38","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","unstructured":"38 Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J Oral Maxillofac Surg. 2009;67(5 Suppl):2-12.","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"key20260817141420_B39","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","unstructured":"39 Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014;72(10):1938-56. Erratum in: J Oral Maxillofac Surg. 2015;73(7):1440. Erratum in: J Oral Maxillofac Surg. 2015;73(9):1879.","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"key20260817141420_B40","doi-asserted-by":"crossref","first-page":"20160065","DOI":"10.1259\/dmfr.20160065","article-title":"Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?","volume":"45","author":"Klingelh\u00f6ffer","year":"2016","unstructured":"40 Klingelh\u00f6ffer C, Klingelh\u00f6ffer M, M\u00fcller S, Ettl T, Wahlmann U. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw? Dentomaxillofac Radiol. 2016;45(5):20160065.","journal-title":"Dentomaxillofac Radiol"},{"key":"key20260817141420_B41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2018.10.014","article-title":"Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate","volume":"120","author":"Ervolino","year":"2019","unstructured":"41 Ervolino E, Statkievicz C, Toro LF, de Mello-Neto JM, Cavazana TP, Issa JP, et al. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone. 2019;120:101-13.","journal-title":"Bone"},{"issue":"5","key":"key20260817141420_B42","doi-asserted-by":"crossref","first-page":"491.e2","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","unstructured":"42 Heifetz-Li JJ, Abdelsamie S, Campbell CB, Roth S, Fielding AF, Mulligan JP. Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128(5):491-497.e2.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"key20260817141420_B43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","unstructured":"43 Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62(5):527-34.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"key20260817141420_B44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","unstructured":"44 Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key20260817141420_B45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10006-020-00831-0","article-title":"Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis","volume":"24","author":"Momesso","year":"2020","unstructured":"45 Momesso GA, Lemos CA, Santiago-J\u00fanior JF, Faverani LP, Pellizzer EP. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis. Oral Maxillofac Surg. 2020;24(2):133-44.","journal-title":"Oral Maxillofac Surg"},{"issue":"6","key":"key20260817141420_B46","doi-asserted-by":"crossref","first-page":"BSR20170658","DOI":"10.1042\/BSR20170658","article-title":"Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K\/Akt\/mTOR signaling pathway","volume":"37","author":"Xiao","year":"2017","unstructured":"46 Xiao W, Tang H, Wu M, Liao Y, Li K, Li L, et al. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K\/Akt\/mTOR signaling pathway. Biosci Rep. 2017;37(6):BSR20170658.","journal-title":"Biosci Rep"},{"issue":"3","key":"key20260817141420_B47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","unstructured":"47 Ripamonti CI, Cislaghi E, Mariani L, Maniezzo M. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study. Oral Oncol. 2011;47(3):185-90.","journal-title":"Oral Oncol"},{"issue":"6","key":"key20260817141420_B48","first-page":"2662","article-title":"Treatment of medication-related osteonecrosis of the jaw (MRONJ)","volume":"25","author":"Goker","year":"2021","unstructured":"48 Goker F, Grecchi E, Grecchi F, Francetti L, Del Fabbro M. Treatment of medication-related osteonecrosis of the jaw (MRONJ). a systematic review. Eur Rev Med Pharmacol Sci. 2021;25(6):2662-73.","journal-title":"a systematic review. Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"key20260817141420_B49","first-page":"25","article-title":"Ozone therapy as an adjunctive strategy for MRONJ in oncology patients: a systematic review and meta-analysis","volume":"34","author":"Carneiro","year":"2025","unstructured":"49 Carneiro MC, da Silva JF, Dos Santos TC, Cardoso CL, da Silva Santos PS. Ozone therapy as an adjunctive strategy for MRONJ in oncology patients: a systematic review and meta-analysis. Support Care Cancer. 2025;34(1):25.","journal-title":"Support Care Cancer"},{"issue":"4","key":"key20260817141420_B50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","unstructured":"50 Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, St\u00fcrzenbaum S, et al. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg. 2012;40(4):303-9.","journal-title":"J Craniomaxillofac Surg"},{"issue":"11","key":"key20260817141420_B51","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.3390\/jcm9113505","article-title":"Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective study","volume":"9","author":"Tenore","year":"2020","unstructured":"51 Tenore G, Zimbalatti A, Rocchetti F, Graniero F, Gaglioti D, Mohsen A, et al. Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective study. J Clin Med. 2020;9(11):3505.","journal-title":"J Clin Med"},{"issue":"1","key":"key20260817141420_B52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1186\/s12903-025-07039-2","article-title":"Evaluation of piezosurgery combined with L-PRF, A-PRF, and photobiomodulation for optimizing MRONJ treatment: an animal study","volume":"25","author":"Jamalpour","year":"2025","unstructured":"52 Jamalpour MR, Shahabi S, Shokri A, Jamshidi S, Khazaei S, Hashemi A, et al. Evaluation of piezosurgery combined with L-PRF, A-PRF, and photobiomodulation for optimizing MRONJ treatment: an animal study. BMC Oral Health. 2025;25(1):1692.","journal-title":"BMC Oral Health"},{"issue":"7","key":"key20260817141420_B53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","unstructured":"53 Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc. 2007;138(7):971-7.","journal-title":"J Am Dent Assoc"},{"issue":"8","key":"key20260817141420_B54","first-page":"654","article-title":"Management of medication-related osteonecrosis of the jaw through the association of surgical treatment with local and systemic adjuvant therapies: a case series with follow-ups of up to 3 years","volume":"56","author":"Faverani","year":"2025","unstructured":"54 Faverani L, Cruz S, Delanora L, Delamura I, Silva M, Fonseca E Santos J, et al. Management of medication-related osteonecrosis of the jaw through the association of surgical treatment with local and systemic adjuvant therapies: a case series with follow-ups of up to 3 years. Quintessence Int. 2025;56(8):654-66.","journal-title":"Quintessence Int"},{"issue":"5","key":"key20260817141420_B55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases","volume":"48","author":"Mozzati","year":"2012","unstructured":"55 Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol. 2012;48(5):469-74.","journal-title":"Oral Oncol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:33Z","timestamp":1786976073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/current-challenges-and-emerging-solutions-in-dentistry-for-treating-medication-related-osteonecrosis-of-the-jaw-mronj-the-state-of-the-art-in-the-era-of-personalized-medicine\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":55,"journal-issue":{"issue":"spe3","published-print":{"date-parts":[[2026,8,14]]}},"alternative-id":["10.31744\/einstein_journal\/2026RW2547"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026rw2547","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eRW2547"}}